Oliver Wyman announced it entered into an agreement to acquire Avascent, an aerospace and defense management consulting firm focused on the corporate and private equity sectors.
The terms of the transaction were not disclosed. The deal is expected to close before the end of the year.
The global management consulting firm and subsidiary of Marsh McLennan said Avascent complements Oliver Wyman’s strong position and reputation across the aviation, aerospace and defense industry globally.
For more than fifteen years, Avascent has been the preeminent specialist management consulting firm serving clients across aerospace, defense, and government sectors. Avascent is also the leading boutique private equity and M&A advisor in the A&D space and the combination of Avascent and Oliver Wyman will create a team with unparalleled experience in both deal and post-transaction work.
“Avascent will complement Oliver Wyman’s expertise, and strengthen it significantly in the Aerospace and Defense sector, both with our corporate and private equity clients,” said Nick Studer, president and CEO, Oliver Wyman. “The company also has a similar business focus – built on deep industry expertise, analytics, impact and collaboration – and we believe these values will benefit our clients.”
Avascent is based in the US, Canada, UK and France and with an extended network of clients and senior advisors around the world. A team of approximately 130 professionals, including 10 partners, will join Oliver Wyman and will be integrated into Oliver Wyman’s Transportation & Services and Private Capital practices.
Topics Mergers & Acquisitions
Was this article valuable?
Here are more articles you may enjoy.
What Disruptions Have Been Reported After the Global Tech Outage? 
Trigger Warning: Cyber Policy Wordings to Impact Coverage for Tech Outage 
Travelers Reverses Q2 Income Loss, Narrows Underwriting Loss 
Viewpoint: Deepfake Fraud Is On the Rise. Here’s How Insurers Can Respond 
